Case CRS – ACTG Network

Location	Case Clinical Research Site 2061 Cornell Road Room 401 Cleveland OH 44106
CRS Coordinator	Jane Baum baum.jane@clevelandactu.org 216-844-2546
CRS Leader	Jeffrey M. Jacobson jxj573@case.edu 215-707-6451
Studies	A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO) A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV A5332: REPRIEVE Trial A5357: A Study of Long-Acting Cabotegravir Plus VRC01LS to Maintain Viral Suppression in HIV-1-Infected Adults A5360: MINMON Study-Monitoring SOF/VEL in Treatment Naïve, Chronic HCV Participants A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) A5368:Anti-PD-1 Antibody in HBV Infected on Suppressive Antiviral Therapy A5395: A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19 A5401: ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B